Promoter and Institution shareholding for Vista Pharmaceuticals is stagnant, indicating no confidence from smart money.

Public shareholding has decreased YoY, which suggests a lack of retail interest or confidence in the stock.

The sector shows no change in shareholding patterns, reflecting a general trend of selling across both Vista and its peers.